The risks of lone atrial fibrillation.

[1]  B. Gersh,et al.  The natural history of lone atrial fibrillation. A population-based study over three decades. , 1987, The New England journal of medicine.

[2]  G. Mcinnes,et al.  The Performance of Clinics for Out-Patient Control of Anticoagulation , 1987, Journal of the Royal College of Physicians of London.

[3]  D. Petitti,et al.  Duration of warfarin anticoagulant therapy and the probabilities of recurrent thromboembolism and hemorrhage. , 1986, The American journal of medicine.

[4]  P. Petersen,et al.  Embolic complications in paroxysmal atrial fibrillation. , 1986, Stroke.

[5]  J. Hirsh,et al.  American College of Chest Physicians and the National Heart, Lung, and Blood Institute National Conference on Antithrombotic Therapy , 1986 .

[6]  V. Fuster,et al.  Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. , 1983, The American journal of cardiology.

[7]  G. Raskob,et al.  Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. , 1982, The New England journal of medicine.

[8]  J. Forfar.  A 7-year analysis of haemorrhage in patients on long-term anticoagulant treatment. , 1979, British heart journal.

[9]  R. Altman,et al.  Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves. , 1976, The Journal of thoracic and cardiovascular surgery.

[10]  W. Evans,et al.  LONE AURICULAR FIBRILLATION , 1954, British heart journal.